Acute non-ST elevation myocardial infarction following paclitaxel administration for ovarian carcinoma: A case report and review of literature

Journal of Cancer Research and Therapeutics

Volumn 8, Issue 3, 2012, Pages 442-444

  Shah, Kajal ^a   Gupta, Sudeep ^a   Ghosh, Jaya ^a   Bajpai, Jyoti ^a   Maheshwari, Amita ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Myocardial infarction; Neoadjuvant chemotherapy; Ovarian carcinoma; Paclitaxel

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADULT; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CASE REPORT; COMORBIDITY; CORONARY ARTERY SPASM; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; EXPLORATORY LAPAROTOMY; FEMALE; HISTOPATHOLOGY; HUMAN; HYPOKINESIA; LAPAROTOMY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OVARY CARCINOMA; PREMENOPAUSE; PRIMARY TUMOR; REVIEW; THORAX PAIN; TRANSTHORACIC ECHOCARDIOGRAPHY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARBOPLATIN; FEMALE; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PACLITAXEL;

EID: 84873388732     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.103530     Document Type: Review

References (10)

1. McGuire WP, Rowinsky EK, Rosenshein NB, Grumbine FC, Ettinger DS, Armstrong DK, et al. Taxol: A unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med 1989;111:273-9.
2. Rowinsky EK, Gilbert MR, McGuire WP, Noe DA, Grochow LB, Forastiere AA, et al. Sequences of taxol and cisplatin: A Phase I and pharmacologic study. J Clin Oncol 1991;9:1692-703.
3. Arbuck SG, Strauss H, Rowinsky E, Christian M, Suffness M, Adams J, et al. A reassessment of cardiac toxicity associated with taxol. J Natl Cancer Inst Monogr 1993;15:117-30.
4. Hekmat E. Fatal myocardial infarction potentially induced by paclitaxel. Ann Pharmacother 1996; 30:1110-2.
5. Nguyen-Ho P, Kleiman NS, Verani MS. Acute myocardial infarction and cardiac arrest in a patient receiving paclitaxel. Can J Cardiol 2003; 19:300-2.
6. Schrader C, Keussen C, Bewig B, von Freier A, Lins M. Symptoms and signs of an acute myocardial ischemia caused by chemotherapy with Paclitaxel (Taxol) in a patient with metastatic ovarian carcinoma. Eur J Med Res 2005;10:498-501.
7. Park SH, Byon JS, Lee SW, Lee SJ, Jin DK, Shin WY. Coronary Artery Thrombosis Associated With Paclitaxel in Advanced Ovarian Cancer. Korean Circ J 2009;39:124-7.
8. Pai VB, Nahata MC. Cardiotoxicity of chemotherapeutic agents: Incidence, treatment and prevention. Drug Saf 2000;22:263-302.
9. Gianni L, Munzone E, Capri G, Fulfaro F, Tarenzi E, Villani F, et al. Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: High antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study. J Clin Oncol 1995;13:2688-99.
10. Barrett-Lee PJ, Dixon JM, Farrell C, Jones A, Leonard R, Murray N, et al. Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk. Ann Oncol 2009;20:816-27.